After elucidating the function of FOXP3 in GBM proliferation and ferroptosis and clarifying its underlying mechanisms, we next evaluated the potential therapeutic effect of the FOXP3-specific inhibitor epirubicin in GBM models. The gene discussed is FOXP3; the disease is glioblastoma.